Literature DB >> 13906401

The plating of tumor components on the subcutaneous expanses of young mice. Findings with benign and malignant epidermal growths and with mammary carcinomas.

J S HENDERSON, P ROUS.   

Abstract

A procedure analogous to the plating of bacteria is described whereby some complex tumors have been taken apart and their components separately propagated. It was the outcome of finding that the forcible injection of Locke's solution followed by air can be used to split the subcutaneous connective tissue of sucklings and weanlings horizontally over the entire expanse of their backs or bellies, without inducing any complicating inflammation. Tumor fragments suspended in Locke's were widely scattered on the surfaces thus exposed. Most of them remained where they had lodged on the body wall, and rapidly becoming fixed in place, formed growths protected by the overlying cutaneous layer-which, throughout many weeks, remained unattached either to the wall or to them. The procedure is more searching in its disclosure of tumor constituents than those currently employed, and it has the advantage that it preserves the neoplastic components that it reveals. It has been used thus far only to rescue for experimental purposes transplantable, benign, epidermal papillomas from the hidden carcinomas deriving from their cells, and to set free and maintain the neoplastic components of complex mammary tumors of milk factor type. Success was obtained with such of the latter as were chosen for separate propagation, though successive platings were sometimes required for their isolation. Incidentally the procedure revealed two components in the mammary growths which could not have been discerned by previous methods of search. Each formed tumors peculiar to itself.

Entities:  

Keywords:  CARCINOMA/experimental

Mesh:

Year:  1962        PMID: 13906401      PMCID: PMC2137402          DOI: 10.1084/jem.115.6.1211

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  9 in total

1.  General character of epidermal papillomas induced by carcinogens on mouse skin as disclosed by transplantation.

Authors:  B S ROOF
Journal:  Proc Soc Exp Biol Med       Date:  1959-10

2.  The histologic analysis of mammary tumors of mice.

Authors:  L FOULDS
Journal:  J Natl Cancer Inst       Date:  1956-12       Impact factor: 13.506

3.  On the mechanism through which hydrocortisone affects the resistance of tissues to injury; an experimental study with the granuloma pouch technique.

Authors:  H SELYE
Journal:  J Am Med Assoc       Date:  1953-07-25

4.  Use of granuloma pouch technic in the study of antiphlogistic corticoids.

Authors:  H SELYE
Journal:  Proc Soc Exp Biol Med       Date:  1953-02

5.  A RAPID METHOD FOR VIABLE CELL TITRATION AND CLONE PRODUCTION WITH HELA CELLS IN TISSUE CULTURE: THE USE OF X-IRRADIATED CELLS TO SUPPLY CONDITIONING FACTORS.

Authors:  T T Puck; P I Marcus
Journal:  Proc Natl Acad Sci U S A       Date:  1955-07-15       Impact factor: 11.205

6.  Experiments on the cause of the rabbit carcinomas derived from virus-induced papillomas. I. Propagation of several of the cancers in sucklings, with etiological tests.

Authors:  W E SMITH; J G KIDD; P ROUS
Journal:  J Exp Med       Date:  1952-03       Impact factor: 14.307

7.  Fatal keratomas due to deep homografts of the benign papillomas of tarred mouse skin; normal proclivities and neoplastic disabilities as determinants of tumor course.

Authors:  P ROUS; R A ALLEN
Journal:  J Exp Med       Date:  1958-01-01       Impact factor: 14.307

8.  ON THE CAUSE OF THE LOCALIZATION OF SECONDARY TUMORS AT POINTS OF INJURY.

Authors:  F S Jones; P Rous
Journal:  J Exp Med       Date:  1914-10-01       Impact factor: 14.307

9.  The quantitative transplantation of sarcoma 37 into subcutaneous air pouches in mice.

Authors:  H B HEWITT
Journal:  Br J Cancer       Date:  1956-09       Impact factor: 7.640

  9 in total
  9 in total

1.  Tumor heterogeneity: biological implications and therapeutic consequences.

Authors:  G H Heppner; B E Miller
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

2.  Cell-cycle fate-monitoring distinguishes individual chemosensitive and chemoresistant cancer cells in drug-treated heterogeneous populations demonstrated by real-time FUCCI imaging.

Authors:  Shinji Miwa; Shuya Yano; Hiroaki Kimura; Mako Yamamoto; Makoto Toneri; Yasunori Matsumoto; Fuminari Uehara; Yukihiko Hiroshima; Takashi Murakami; Katsuhiro Hayashi; Norio Yamamoto; Michael Bouvet; Toshiyoshi Fujiwara; Hiroyuki Tsuchiya; Robert M Hoffman
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

3.  Cellular heterogeneity in an ethylnitrosourea-induced glioma: malignancy, karyology and other properties of tumour cell types.

Authors:  P J Claisse; J P Roscoe; P L Lantos
Journal:  Br J Exp Pathol       Date:  1979-04

4.  The selective nature of metastasis.

Authors:  J E Talmadge
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

5.  Adjuvators to the propagation of mouse mammary tumor cells on expanses of subcutaneous tissue.

Authors:  J S Henderson
Journal:  J Exp Med       Date:  1967-01-01       Impact factor: 14.307

6.  The propagation of cancer, a process of tissue remodeling. Studies in histophysiologic gradient culture.

Authors:  J Leighton; R Tchao
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

Review 7.  Experimental systems for analysis of the malignant phenotype.

Authors:  G Poste
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

8.  Interference by cortisone with endotoxin's adjuvator action on transplantation of a mouse tumour.

Authors:  J S Henderson; R D Migliore; D Berbrayer
Journal:  Br J Cancer       Date:  1976-02       Impact factor: 7.640

9.  Heterogeneity of tumorigenicity phenotype in murine tumors. I. Characterization of regressor and progressor clones isolated from a nonmutagenized ultraviolet regressor tumor.

Authors:  M Schmitt; R A Daynes
Journal:  J Exp Med       Date:  1981-05-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.